• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Bloomberg: Reimbursement woes dog Boston Scientific’s Alair
Boston Scientific (NYSE:BSX) has struggled to get U.S. insurers on board with its Alair bronchial thermoplasty treatment system for asthma patients, according to a new report from Bloomberg Business published last Friday. Concerns over the risk of complications, the availability of inexpensive asthma drugs and the potential for the disease to clear up on its own are at the heart of what is keeping insurers away, Bloomberg reported. “Bronchial thermoplasty is considered investigational and not medically necessary for the treatment of asthma. This procedure has real and significant complications and the ongoing concer...
Source: Mass Device - July 20, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters Respiratory Source Type: news

ACAAI endorses Boston Scientific’s Alair asthma treatment
Boston Scientific (NYSE:BSX) said yesterday that the American College of Allergy, Asthma and  Immunology has endorsed bronchial thermoplasty using the company’s Alair system. The ACAAI recommends the procedure for patients with severe asthma who continue to present symptoms despite maximum medication treatment, Marlborough, Mass.-based Boston Scientific said. In bronchial thermoplasty, thermal energy is delivered to the airway wall to reduce excessive smooth muscle, decreasing the ability of the airway to constrict, which reduces the frequency and severity of asthma attacks, the company said. “Allergists see ...
Source: Mass Device - July 10, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Otolaryngology Ear, Nose & Throat American College of All Boston Scientific Source Type: news